During the past decade, Frauenklinik Wetzlar conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Frauenklinik Wetzlar" are "Metastatic Breast Cancer" (2 trials), "Breast Neoplasms" (1 trials) and "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Frauenklinik Wetzlar" in a lesser frequency.

Most popular intervention types in "Frauenklinik Wetzlar" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Giredestrant" (1 trials), "Giredestrant-matched Placebo" (1 trials), "Herceptin" (1 trials), "LHRH Agonist" (1 trials) and "Letrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Frauenklinik Wetzlar" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Frauenklinik Wetzlar". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Frauenklinik Wetzlar, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Frauenklinik Wetzlar, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".